![Katharine Knobil](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Katharine Knobil
Directeur/Bestuurslid bij
MARKER THERAPEUTICS, INC.
Vermogen: 236 $ op 31-05-2026
Profiel
Momenteel bekleedt Katharine Knobil de functie van Chief Medical Officer van Agilent Technologies, Inc. Dr. Knobil is tevens lid van de raad van bestuur van Arena Pharmaceuticals, Inc. en lid van The National Academies of Science. Dr. Knobil was eerder werkzaam als Chief Medical Officer, Head-Research & Development bij Kaleido Biosciences, Inc. en als Chief Medical Officer & Senior Vice President bij GlaxoSmithKline LLC. Dr. Knobil behaalde een doctoraal aan de Cornell University en een doctoraat aan The University of Texas Southwestern Medical Center.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-03-2026 | 150 ( 0% ) | 236 $ | 31-05-2026 | |
-.--% | 10-06-2026 | 0 ( -.--% ) | - $ | 31-05-2026 |
| 15-04-2026 | 0 ( -.--% ) | - $ | 31-05-2026 |
Actieve functies van Katharine Knobil
| Bedrijven | Functie | Begin |
|---|---|---|
| MARKER THERAPEUTICS, INC. | Directeur/Bestuurslid | 08-12-2021 |
The National Academies of Science
 The National Academies of Science Miscellaneous Commercial ServicesCommercial Services Provides advice and reports in sciences, engineering and medicine | Corporate Officer/Principal | - |
Nimbus Therapeutics LLC
 Nimbus Therapeutics LLC BiotechnologyHealth Technology Operates as a clinical stage biotech company that develops molecule medicines for diseases like cancer, immune disorders and metabolic conditions | Directeur/Bestuurslid | - |
Altesa Biosciences, Inc.
 Altesa Biosciences, Inc. BiotechnologyHealth Technology Develops oral recombinant vaccines | Hoofd Techniek/Wetenschap/O&O | - |
Infinant Health, Inc.
 Infinant Health, Inc. BiotechnologyHealth Technology Develops novel solutions to resolve the dysbiosis | Directeur/Bestuurslid | - |
Eerdere bekende functies van Katharine Knobil
| Bedrijven | Functie | Einde |
|---|---|---|
| PLIANT THERAPEUTICS, INC. | Directeur/Bestuurslid | 11-06-2026 |
| AGILENT TECHNOLOGIES, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2024 |
| ARENA PHARMACEUTICALS | Directeur/Bestuurslid | 11-03-2022 |
| KALEIDO BIOSCIENCES, INC. | Hoofd Techniek/Wetenschap/O&O | 29-01-2021 |
| ░░░ ░░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Opleiding van Katharine Knobil
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
67
Eerstegraads connecties
14
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 14 |
|---|---|
Agilent Technologies, Inc.
 Agilent Technologies, Inc. Medical SpecialtiesHealth Technology Engages in life sciences, diagnostics and applied chemical markets | Health Technology |
Marker Therapeutics, Inc.
 Marker Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes cell based immune therapeutics and vaccines for cancer treatment | Health Technology |
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Nimbus Therapeutics LLC
Nimbus Therapeutics LLC BiotechnologyHealth Technology Operates as a clinical stage biotech company that develops molecule medicines for diseases like cancer, immune disorders and metabolic conditions | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The National Academies of Science
The National Academies of Science Miscellaneous Commercial ServicesCommercial Services Provides advice and reports in sciences, engineering and medicine | Commercial Services |
The National Health Council
 The National Health Council Miscellaneous Commercial ServicesCommercial Services Provides united voice for people with chronic diseases and disabilities and their family caregivers | Commercial Services |
The University of Texas Southwestern Medical Center
 The University of Texas Southwestern Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Patient-Centered Outcomes Research Institute
 Patient-Centered Outcomes Research Institute Miscellaneous Commercial ServicesCommercial Services Operates as non-profit organization to funds research that helps patients and care takers to make better decisions about their healthcare choices | Commercial Services |
Infinant Health, Inc.
Infinant Health, Inc. BiotechnologyHealth Technology Develops novel solutions to resolve the dysbiosis | Health Technology |
Pliant Therapeutics, Inc.
 Pliant Therapeutics, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company focuses on discovering and developing novel therapies for the treatment of fibrosis | Health Technology |
Kaleido Biosciences, Inc.
 Kaleido Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company which develops therapeutic products to systematically shape the micro biome | Health Technology |
Altesa Biosciences, Inc.
Altesa Biosciences, Inc. BiotechnologyHealth Technology Develops oral recombinant vaccines | Health Technology |
